PR Newswire
WASHINGTON, Sept. 29, 2020
LUNGevity Foundation and American Cancer Society Cancer Action Network report indicates some improvement but substantial gaps still exist for many patients
WASHINGTON, Sept. 29, 2020 /PRNewswire/ — LUNGevity Foundation, the nation’s premier lung cancer-focused nonprofit organization, in partnership with the American Cancer Society Cancer Action Network (ACS CAN), issued a report today analyzing private payer health insurance coverage of biomarker testing for non-small cell lung, colorectal, breast, and prostate cancers. The study serves as an update to a similar review of health care coverage issued by both organizations in 2018.
Since 2015, LUNGevity has been working to ensure that all advanced-stage non-small cell lung cancer patients have access to comprehensive biomarker testing at diagnosis, progression, and recurrence, and have the results before making treatment decisions. LUNGevity defines comprehensive biomarker testing as a multiplex panel (also referred to as a multi-gene panel in the report, such as a Next Generation Sequencing panel) to detect multiple mutations including, at a minimum, EGFR, ALK, ROS-1, BRAF, NTRK, RET, MET, HER-2, KRAS, and an immunohistochemistry test to measure levels of the protein PDL1.
Limitations in health care insurance coverage often affect access to these vital advances, which leads to disparities in treatment. The report found that private payer health care coverage is more prominent for single-gene tests. However, health insurance companies are still slow to cover targeted multiplex panels and other forms of testing, such as minimally invasive liquid biopsies, also known as blood-based biomarker testing.
“LUNGevity is proud to partner with ACS CAN on this study as part of our ongoing commitment to improving the lives of cancer patients,” explained LUNGevity Senior Director of Public Policy Initiatives Kristen
I want to offer some insights as to why I consider such a high percentage of Insurance Agents fail of their first couple years in the insurance business. This verbiage is included right into a policy to help hold the rising cost of affected person accountability to member at a minimal and make the process of seeing a medical practitioner much simpler. Clayton I didn’t assume you had been effectively off your self, there isn’t any doubt that quite a lot of individuals financially challenged are protesting in opposition to health care reform.
A deductible is a particular dollar amount that your health insurance company requires that you simply pay out of your pocket annually before the health insurance firm begins to make funds for claims. The reasons cited are the burden of the uninsured, high costs, not sufficient patients, and the high price of administration due to having to file and refile and battle consistently with the insurance companies. The cost of health care abroad, for a international customer, could also be high.
When as I was starting out with my first enterprise, my associates had seen that I hardly exit anymore. Almost seventy five million people in Sub-Saharan Africa are estimated to have paid a bribe prior to now yr – some to escape punishment by the police or courts, but many compelled to pay to get entry to the basic companies that they desperately want (Transparency International 2015).